Healthcare

Return the favour: South Korea looks to U.S. for COVID-19 vaccine aid

South Korea hopes the United States will help it tackle a shortage of coronavirus vaccine in return for test kits and masks Seoul sent to Washington earlier in the pandemic, the foreign minister said on Wednesday.

The government has drawn fire from the media for not doing enough to secure enough vaccines early, with just 3% of the population inoculated, due to tight global supply and limited access.

“We have been stressing to the United States that ‘A friend in need is a friend indeed,'” the minister, Chung Eui-yong, told reporters at the Kwanhun Club of South Korean journalists.

He said South Korea had airlifted Washington a large volume of coronavirus test kits and face masks in the early stages of the pandemic “in the spirit of the special South Korea-U.S. alliance,” despite tight domestic supply at the time.

“We are hoping that the United States will help us out with the challenges we are facing with the vaccines, based on the solidarity we demonstrated last year.”

The allies were in talks, added Chung, who also flagged South Korea’s potential contribution to preserving a global semiconductor supply chain U.S. President Joe Biden is keen to maintain.

Diplomatic efforts have not yielded any concrete steps, however, as the talks with Washington are still in an early stage, health ministry official Son Young-rae told reporters.

Opposition lawmaker Park Jin urged more aggressive vaccine diplomacy, calling for the government to invoke its free trade pact (FTA) with Washington to secure pharmaceutical products.

“The government needs to be more proactive,” Park told Reuters.

“The FTA provides us a legal base to demand (vaccines) as it stipulates the two countries’ commitment to promoting the development of, and facilitating access to, pharmaceutical products.”

The U.S. embassy in Seoul did not immediately reply to a Reuters’ request for comment.

About 1.77 million people in South Korea have had their first dose of the AstraZeneca Plc (AZN.L) or Pfizer (PFE.N) vaccines. The low rate compares with a 40% vaccination rate in the United States, according to Reuters data.

Tuesday’s 731 new coronavirus infections, up from 549 cases a day earlier, took South Korea’s tally to 115,926, with 1,806 deaths.

(Global vaccination tracker: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/vaccination-rollout-and-access/)

Our Standards: The Thomson Reuters Trust Principles.

Source: https://www.reuters.com/world/asia-pacific/return-favour-south-korea-looks-us-covid-19-vaccine-aid-2021-04-21/

World Economic Magazine

Recent Posts

Global Fashion Summit 2026, Copenhagen Sets Its Vision on Building Resilient Futures

Global Fashion Agenda has revealed Building Resilient Futures as the theme for the Global Fashion…

5 minutes ago

Huawei Wins Best Technology Provider Award at Electricity Connect 2025

The Electricity Connect 2025 conference in Jakarta spotlighted Indonesia’s energy transition, with Huawei recognised as…

28 minutes ago

3D Printed Boats Prepare to Rewrite the Future of Marine Manufacturing

After years of material science breakthroughs, a team proved that a rugged, sea-ready composite could…

1 day ago

TAHO Raises 3.5 Million Seed Round to Redefine Compute Infrastructure for the AI Era

TAHO, a Venice-based compute startup founded by ex-Meta and Google engineers, raised $3.5 million in…

3 days ago

Squirrel AI Founder Haoyang Li Spotlights Global Talent Transformation

The 9th Future Investment Initiative in Riyadh spotlighted how AI is rapidly redefining global growth,…

4 days ago

Onward Robotics Names Brendon Bielat Chief Product Officer

Onward Robotics has appointed Brendon Bielat as Chief Product Officer, strengthening its leadership team as…

5 days ago